Lifecome Biochemistry Co.,Ltd. (002868.SZ)
CNY 15.88
(-2.87%)
CNY 15.88
(-2.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -186.75 Million | -8.83 Million | 35.17 Million | 90.72 Million | 74.08 Million | 83.69 Million |
| Net Income | -222.61 Million | -122.72 Million | -26.44 Million | 42.93 Million | 56.83 Million | 74.68 Million |
| Depreciation & Amortization | 71.06 Million | 64.17 Million | 33.94 Million | 30.45 Million | 28.62 Million | 29.73 Million |
| Deferred income taxes | -18.27 Million | -11.38 Million | -5.97 Million | 2.99 Million | 3.28 Million | 283.94 Thousand |
| Stock-based compensation | 1.72 Million | - | - | - | - | - |
| Change in working capital | -151.58 Million | -27.38 Million | -4.14 Million | 22.83 Million | 3.37 Million | -6.7 Million |
| Other non-cash items | 37.32 Million | 77.1 Million | 31.81 Million | -5.5 Million | -14.74 Million | -14.02 Million |
| Investing Cash Flow | -254.24 Million | -136.85 Million | -355.01 Million | 86.57 Million | -123.13 Million | -55.95 Million |
| Investments in PPE | -464.53 Million | -137.32 Million | -357.16 Million | -253.79 Million | -125.6 Million | -48.93 Million |
| Acquisitions | 204.04 Million | 18.72 Thousand | 4.24 Million | 3.28 Million | 125.6 Million | - |
| Investment purchases | - | -18.71 Thousand | -4.24 Million | -290 Million | -607.6 Million | -698.8 Million |
| Sales/Maturities of investments | 1.31 Million | 444.43 Thousand | 1.39 Million | 623.61 Million | 610.06 Million | 686.02 Million |
| Other Investing Activities | 301.17 Million | 18.72 Thousand | 762.76 Thousand | 3.48 Million | -125.6 Million | 5.76 Million |
| Financing Cash Flow | 467.45 Million | 70.76 Million | 223.86 Million | -94.76 Million | 94.36 Million | -30.69 Million |
| Debt repayment | -455.41 Million | -254.89 Million | -36.05 Million | -133.52 Million | -25 Million | -1.21 Million |
| Dividends payments | -24.22 Million | -12.99 Million | -21.47 Million | -20.06 Million | -30 Million | -30.02 Million |
| Common Stock Repurchased | - | - | - | -32.42 Million | - | - |
| Common Stock Issuance | 35.7 Million | - | - | 32.42 Million | - | - |
| Other Financing Activities | 36.26 Million | 338.65 Million | 286.44 Million | 62.37 Million | 150.88 Million | 547.94 Thousand |
| Accounts receivables | -51.57 Million | -3.78 Million | -17.22 Million | 44.09 Million | -1.76 Million | 822.84 Thousand |
| Accounts payables | 15.66 Million | 61.29 Million | 34.48 Million | -18.77 Million | 7.06 Million | 6.67 Million |
| Inventory | -97.39 Million | -73.5 Million | -15.42 Million | -5.47 Million | -5.2 Million | -14.49 Million |
| Other working capital | 4.61 Million | -11.38 Million | -5.97 Million | 2.99 Million | 3.28 Million | 7.78 Million |
| Cash at beginning of period | 25.76 Million | 97.49 Million | 194.26 Million | 114.31 Million | 68.68 Million | 71.18 Million |
| Cash at end of period | 52.18 Million | 25.76 Million | 97.49 Million | 194.26 Million | 114.31 Million | 68.68 Million |
| Capital Expenditure | -464.53 Million | -137.32 Million | -357.16 Million | -253.79 Million | -125.6 Million | -48.93 Million |
| Effect of forex changes on cash | -16.54 Thousand | 3.19 Million | -795.07 Thousand | -2.58 Million | 305.06 Thousand | 445.3 Thousand |
| Net cash flow / Change in cash | 26.42 Million | -71.73 Million | -96.76 Million | 79.95 Million | 45.62 Million | -2.49 Million |
| Free Cash Flow | -651.29 Million | -146.15 Million | -321.99 Million | -163.06 Million | -51.51 Million | 34.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -69.9 Million | -55.73 Million | -31.34 Million | -222.61 Million | -135.73 Million | -39.41 Million |
| Depreciation & Amortization | - | 25.08 Million | 25.08 Million | 71.06 Million | 71.06 Million | -34.01 Million |
| Deferred income taxes | - | - | - | -18.27 Million | - | - |
| Stock-based compensation | - | 1.47 Million | - | 1.72 Million | 1.72 Million | - |
| Change in working capital | - | 54.56 Million | - | -151.58 Million | -144.35 Million | 88.49 Million |
| Other non-cash items | 119.87 Million | 159.57 Million | 16.09 Million | 37.32 Million | 144.83 Million | -37.03 Million |
| Investing Cash Flow | 15.91 Million | 24.71 Million | -55.08 Million | -254.24 Million | -130.36 Million | -194.39 Million |
| Investments in PPE | 9.76 Million | -63.94 Million | -55.08 Million | -464.53 Million | -135.28 Million | -195.7 Million |
| Acquisitions | 6.14 Million | 88.66 Million | - | 204.04 Million | 4.92 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 1.31 Million | - | - |
| Other Investing Activities | - | 88.66 Million | - | 301.17 Million | 4.92 Million | 1.31 Million |
| Financing Cash Flow | -83.4 Million | -108.55 Million | 53.23 Million | 467.45 Million | 26.65 Million | 326 Million |
| Debt repayment | -25.21 Million | -23.6 Million | -64.01 Million | -455.41 Million | -78.07 Million | -98.89 Million |
| Dividends payments | - | -14.11 Million | -8.93 Million | -24.22 Million | -13.39 Million | -4.21 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 35.7 Million | 35.7 Million | - |
| Other Financing Activities | -108.61 Million | -70.83 Million | -10.77 Million | 36.26 Million | -38.03 Million | 429.11 Million |
| Accounts receivables | - | 49.68 Million | - | -51.57 Million | -51.57 Million | 40.27 Million |
| Accounts payables | - | - | - | 15.66 Million | - | 426.44 Thousand |
| Inventory | - | -19.98 Million | - | -97.39 Million | -97.39 Million | 48.21 Million |
| Other working capital | - | 24.86 Million | - | 4.61 Million | 4.61 Million | -426.44 Thousand |
| Cash at beginning of period | 31.59 Million | 68.38 Million | 220.31 Million | 25.76 Million | 220.31 Million | 110.43 Million |
| Cash at end of period | 14.52 Million | 28.17 Million | 32.29 Million | 52.18 Million | 52.18 Million | 220.31 Million |
| Capital Expenditure | 9.76 Million | -63.94 Million | -55.08 Million | -464.53 Million | -135.28 Million | -195.7 Million |
| Effect of forex changes on cash | - | -2.92 Million | 1.09 Million | -16.54 Thousand | -224.56 Thousand | 244.56 Thousand |
| Net cash flow / Change in cash | -17.06 Million | -40.2 Million | -188.02 Million | 26.42 Million | -168.12 Million | 109.88 Million |
| Free Cash Flow | 59.73 Million | 14.8 Million | -70.33 Million | -651.29 Million | -199.48 Million | -217.67 Million |
PNTR
TVTODAY
603099
3038
002623
PBSFY